The exercise period for warrants of series TO5 in JonDeTech Sensors AB (publ) begins today
THE INFORMATION CONTAINED IN THIS PRESS RELEASE MAY NOT BE DISCLOSED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED KINGDOM OR ANY OTHER JURISDICTION WHERE SUCH DISCLOSURE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION UNDER APPLICABLE REGULATIONS.
JonDeTech Sensors AB (publ) (“JonDeTech” or the “Company”) completed a rights issue of units, consisting of shares and warrants of series TO5, during the second quarter of 2026. The subscription price upon exercise of the TO5 warrants is SEK 0.60 per share. One (1) warrant of series TO5 entitles the holder to subscribe for one (1) new share in the Company. The exercise period for warrants of series TO5 runs from October 26, 2026 up to and including November 9, 2026.
The Board of Directors wishes to inform holders of warrants of series TO5 that, as of the date of this press release, the subscription price upon exercise of the warrants exceeds the current market price of JonDeTech’s shares on NGM Growth Market.
If all warrants of series TO5 are exercised, the Company will receive approximately SEK 24.8 million before issue costs. To prevent the warrants from expiring worthless, holders must actively exercise their warrants to subscribe for new shares no later than November 9, 2026, or alternatively sell their warrants no later than November 4, 2026. Please note that certain nominees may have earlier deadlines for submitting exercise instructions than November 9, 2026.
The full terms and conditions of the warrants are available on the Company’s website, www.jondetech.com.
Summary of the terms and conditions of the warrants of series TO5:
Exercise period: October 26, 2026 – November 9, 2026.
Subscription price: SEK 0.60 per share.
Issue volume: A total of 41,387,968 warrants of series TO5 entitle the holders to subscribe for 41,387,968 shares. If all warrants are exercised, the Company will receive approximately SEK 24.8 million before issue costs.
Last day of trading in warrants of series TO5: November 4, 2026.
Share capital and dilution: If all warrants are exercised, the share capital will increase by SEK 7,780,937.984, from SEK 18,720,476.564 to SEK 26,501,414.548. The number of shares will increase by 41,387,968, from 99,577,003 shares to 140,964,971 shares. The dilution resulting from full exercise of the warrants will amount to approximately 29.4 percent of the total number of shares.
Please note that warrants not exercised by November 9, 2026 or sold by November 4, 2026 will expire worthless. To prevent the warrants from expiring worthless, holders must actively exercise their warrants to subscribe for shares or sell their warrants before the respective deadlines.
How to exercise the warrants:
Nominee-registered warrants (custody account):
Subscription and payment through the exercise of warrants must be carried out in accordance with the instructions provided by the respective nominee. Please contact your nominee for further information.
Directly registered warrants (VP account):
No settlement notice or payment instructions will be sent out. Subscription must be made through simultaneous cash payment in accordance with the instructions provided on the subscription form. The warrants will subsequently be replaced by interim shares pending registration with the Swedish Companies Registration Office.
The subscription form, including payment instructions, will be available on the Company’s website at www.jondetech.com.
Advisors
Mangold Fondkommission AB is acting as financial advisor and Eversheds Sutherland Advokatbyrå as legal advisor to JonDeTech in connection with the exercise of warrants of series TO5.
For more information, please contact:
Jonas Wærn, CEO
tel: +46 703 22 86 63
jonas.waern@jondetech.com
About JonDeTech
JonDeTech is a Swedish high-tech company developing digital and analogue heat sensors for measuring Core Body Temperature (CBT). The Company’s patented sensor technology combines a very small form factor with high accuracy and low power consumption, enabling integration into high-volume products such as wearables, medical sensors and other consumer products. The technology is designed to enable continuous body temperature monitoring in mass-produced consumer products, representing the next major technological step in digital health and wearables as body temperature data becomes as established as heart rate monitoring. JonDeTech operates through a global network of distributors and partners, with the objective of supplying sensors to leading global players in consumer electronics and digital health.
JonDeTech’s share is listed on NGM Growth Market.
Read more at www.jondetech.com.
Important Information
The publication, disclosure or distribution of this press release may be subject to restrictions in certain jurisdictions. Recipients of this press release in jurisdictions where it has been published, disclosed or distributed should inform themselves about and comply with any such restrictions. This press release does not constitute an offer to sell or an invitation to acquire or subscribe for any securities in JonDeTech in any jurisdiction.
This press release does not constitute an offer to sell or an invitation to acquire or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States unless registered under the U.S. Securities Act of 1933, as amended, or pursuant to an applicable exemption from registration requirements. The information contained in this press release may not be disclosed, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, in or into the United States, Australia, Belarus, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, the United Kingdom, South Africa, South Korea or any other jurisdiction where such disclosure, publication or distribution would violate applicable laws or regulations. Any action in violation of these restrictions may constitute a breach of applicable securities laws.